Patent details

EP2468290 Title: Activin-ActRII Antagonists for use in treating anemia

Basic Information

Publication number:
EP2468290
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111951307
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Activin-ActRII Antagonists for use in treating anemia
French Title of Invention:
Antagonistes de L'Activine-ActRII pour leur utilisation dans le traitement de l'anémie
German Title of Invention:
Activin-AcrtRII-Antagonisten zur Verwendungen zur Behandlung von Anämie
SPC Number:

Dates

Filing date:
18/12/2007
Grant date:
01/04/2015
EP Publication Date:
01/04/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/06/2012
EP B1 Publication Date:
01/04/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/12/2015
Expiration date:
18/12/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/12/2007
 
 

Name:
Acceleron Pharma Inc.
Address:
149 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

Name:
Sherman Matthew L.
Address:
United States (US)

Priority

Priority Number:
87568206 P
Priority Date:
18/12/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/17;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages